Concordance of circulating tumor DNA and imaging surveillance in patients with urothelial carcinoma and renal cell carcinoma post-immunotherapy.

During a live event, Alexander I. Spira, MD, PhD, and participants NGS testing practices and the rationale behind their ...

Predicting how cancer patients will respond to treatment remains a critical challenge. Immune checkpoint inhibitors (ICIs), a ...

in a Chinese PD-L1-positive non-small cell lung cancer (NSCLC) population. That led some market observers to predict the drug could become a 'Keytruda killer' and potentially a replacement for ...

for the combination compared to historical controls like anti-PD-1/PD-L1 and anti-CTLA4 drugs, while BNT111 and Libtayo monotherapy also showed evidence of clinical activity, according to BioNTech.

When PD-1 binds to PD-L1 or PD-L2 on tumor cells or other cells, T cell functions are subdued. Checkpoint blockade treatments interrupt this interaction. This allows stem–like T cells to proliferate ...

Infusion reactions that can sometimes be severe or life-threatening. Signs and symptoms of infusion reactions may include: ...

Recombinant human TSH (rhTSH) was developed to provide TSH stimulation without the requirement for THST withdrawal and the ...

Colorectal cancer (CRC), which affects the colon or rectum, represents a significant public health challenge. It ranks as the ...

After hours: February 20 at 6:14:15 PM EST ...

Sony Xperia L1 mobile was launched in March 2017. The phone comes with a 5.50-inch touchscreen display offering a resolution of 720x1280 pixels. Sony Xperia L1 is powered by a 1.45GHz quad-core ...